| CD34+ and Endothelial Progenitor Cells in Patients With Various Degrees of Congestive Heart Failure M Valgimigli, GM Rigolin, A Fucili, MD Porta, O Soukhomovskaia, ... Circulation 110 (10), 1209-1212, 2004 | 489 | 2004 |
| Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies: a randomized, placebo-controlled, double-blind … F Menichetti, A Del Favero, P Martino, G Bucaneve, A Micozzi, ... Clinical infectious diseases 28 (2), 250-255, 1999 | 303 | 1999 |
| Use of granulocyte-colony stimulating factor during acute myocardial infarction to enhance bone marrow stem cell mobilization in humans: clinical and angiographic safety profile M Valgimigli, GM Rigolin, C Cittanti, P Malagutti, S Curello, G Percoco, ... European heart journal 26 (18), 1838-1845, 2005 | 302 | 2005 |
| Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia D Rossi, L Terzi-di-Bergamo, L De Paoli, M Cerri, G Ghilardi, A Chiarenza, ... Blood, The Journal of the American Society of Hematology 126 (16), 1921-1924, 2015 | 249 | 2015 |
| COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus L Scarfò, T Chatzikonstantinou, GM Rigolin, G Quaresmini, M Motta, ... Leukemia 34 (9), 2354-2363, 2020 | 220 | 2020 |
| A randomized double‐blind placebo‐controlled study with subcutaneous recombinant human erythropoietin in patients with low‐risk myelodysplastic syndromes I talian C ooperative S tudy G roupfor rHuEpo in M yelodysplastic S yndromes British Journal of Haematology 103 (4), 1070-1074, 1998 | 179 | 1998 |
| Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact P Baliakas, S Jeromin, M Iskas, A Puiggros, K Plevova, F Nguyen-Khac, ... Blood, The Journal of the American Society of Hematology 133 (11), 1205-1216, 2019 | 172 | 2019 |
| Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA … AC Rawstron, KA Kreuzer, A Soosapilla, M Spacek, O Stehlikova, ... Cytometry Part B: Clinical Cytometry 94 (1), 121-128, 2018 | 165 | 2018 |
| Chronic lymphocytic leukemia with 6q− shows distinct hematological features and intermediate prognosis A Cuneo, GM Rigolin, R Bigoni, C De Angeli, A Veronese, F Cavazzini, ... Leukemia 18 (3), 476-483, 2004 | 153 | 2004 |
| Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes MG Della Porta, E Travaglino, E Boveri, M Ponzoni, L Malcovati, ... Leukemia 29 (1), 66-75, 2015 | 145 | 2015 |
| Drug resistance and BCR‐ABL kinase domain mutations in Philadelphia chromosome–positive acute lymphoblastic leukemia from the imatinib to the second‐generation tyrosine kinase … S Soverini, C De Benedittis, C Papayannidis, S Paolini, C Venturi, ... Cancer 120 (7), 1002-1009, 2014 | 141 | 2014 |
| Chlorambucil plus rituximab with or without maintenance rituximab as first‐line treatment for elderly chronic lymphocytic leukemia patients R Foà, I Del Giudice, A Cuneo, G Del Poeta, S Ciolli, F Di Raimondo, ... American journal of hematology 89 (5), 480-486, 2014 | 140 | 2014 |
| Gene polymorphisms in folate metabolizing enzymes in adult acute lymphoblastic leukemia: effects on methotrexate-related toxicity and survival A Ongaro, M De Mattei, MG Della Porta, GM Rigolin, C Ambrosio, ... haematologica 94 (10), 1391, 2009 | 129 | 2009 |
| Cytogenetic profile of lymphoma of follicle mantle lineage: correlation with clinicobiologic features A Cuneo, R Bigoni, GM Rigolin, MG Roberti, A Bardi, N Piva, R Milani, ... Blood, The Journal of the American Society of Hematology 93 (4), 1372-1380, 1999 | 126 | 1999 |
| Neoplastic circulating endothelial cells in multiple myeloma with 13q14 deletion GM Rigolin, C Fraulini, M Ciccone, E Mauro, AM Bugli, C De Angeli, ... Blood 107 (6), 2531-2535, 2006 | 125 | 2006 |
| Clinical importance of interphase cytogenetics detecting occult chromosome lesions in myelodysplastic syndromes with normal karyotype GM Rigolin, R Bigoni, R Milani, F Cavazzini, MG Roberti, A Bardi, ... Leukemia 15 (12), 1841-1847, 2001 | 123 | 2001 |
| Dendritic cells and vascular endothelial growth factor in colorectal cancer: correlations with clinicobiological findings M Della Porta, M Danova, GM Rigolin, S Brugnatelli, B Rovati, C Tronconi, ... Oncology 68 (2-3), 276-284, 2005 | 115 | 2005 |
| Chromosome 14q32 translocations involving the immunoglobulin heavy chain locus in chronic lymphocytic leukaemia identify a disease subset with poor prognosis F Cavazzini, JA Hernandez, A Gozzetti, A Russo Rossi, C De Angeli, ... British journal of haematology 142 (4), 529-537, 2008 | 113 | 2008 |
| Exposure to myelotoxic agents and myelodysplasia: case–control study and correlation with clinicobiological findings GM Rigolin, A Cuneo, MG Roberti, A Bardi, R Bigoni, N Piva, C Minotto, ... British journal of haematology 103 (1), 189-197, 1998 | 111 | 1998 |
| Late appearance of the 11q22. 3-23.1 deletion involving the ATM locus in B-cell chronic lymphocytic leukemia and related disorders. Clinico-biological significance A Cuneo, R Bigoni, GM Rigolin, MG Roberti, A Bardi, F Cavazzini, ... haematologica 87 (1), 44-51, 2002 | 88 | 2002 |
